Skip To Main Content

One minute to ignite new thinking in COPD

Understanding type 2 inflammation* may help shed light on why some patients continue to exacerbate. Watch this video to learn how.1

What if you could identify higher-risk patients?

A deeper look at the inflammation behind exacerbations could ignite new thinking in COPD. Look for blood eosinophils, a biomarker of COPD with Type 2 Inflammation*, which may help you identify those patients at increased risk of exacerbations.1

Watch the video below to better understand exacerbations in COPD and better identify patients at risk.1

Ignite new thinking in COPD - COPD, chronic obstructive pulmonary disease

In patients with COPD, exacerbations may :

  • Increase the risk of another1
  • Accelerate lung function decline2
  • Increase morbidity and mortality risk1,3-6

Different types of chronic inflammation have an important role in COPD7-15
Type 2 inflammation and beyond type 2 inflammation
Identifying COPD patients with type 2 inflammation may help determine those at increased risk of exacerbations16
Look for blood eosinophils, a biomarker of COPD with type 2 inflammation17,18,a,b
EOS ≥ 300 cells/ μL à 32% increased risk of COPD exacerbations16a,b
Understanding type 2 inflammation in COPD may shed light on why some patients continue to experience exacerbations

References

MAT-BE-2400702